Efficacy of belinostat in advanced hepatocellular carcinoma (HCC): Phase I and II multicentered study of the Mayo Phase 2 Consortium (P2C) and the Cancer Therapeutics Research Group (CTRG)

被引：1

作者：

Chan, Stephen Lam

Chung, Hyun Cheol

Wang, Ling-Zhi

Lim, Robert S. C.

Picus, Joel

Boyer, Michael J.

Erlichman, Charles

Chan, Anthony T. C.

Goh, Boon C.

Yeo, Winnie

机构：

[1] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Shatin, Peoples R China

[2] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Canc Metastasis Res Ctr, Shinchon dong, South Korea

[3] Canc Sci Inst, Singapore, Singapore

[4] Natl Univ Singapore Hosp, Singapore, Singapore

[5] Washington Univ, Sch Med, St Louis, MO USA

[6] Sydney Canc Ctr, Sydney, NSW, Australia

[7] Mayo Clin, Rochester, MN USA

[8] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Peoples R China

[9] Natl Univ Hlth Syst, Singapore, Singapore

[10] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Peoples R China

来源：

关键词：

D O I：

10.1200/jco.2012.30.4_suppl.259

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

259

引用

页数：2